Latest S-1 registration statements

Exicure, Inc. is undergoing a significant strategic shift, divesting historical biotechnology assets to focus on new ventures including a blood cancer clinical trial and Korean entertainment and renewable energy businesses, while actively raising capital to address substantial doubt about its ability to continue as a going concern.

NIQ Global Intelligence plc, a leading consumer intelligence company, filed an S-1/A registration statement for its initial public offering of 50 million ordinary shares, aiming to repay debt and continue its strategic growth initiatives driven by AI and expanded market coverage.

McGraw Hill, Inc. has filed an amendment to its S-1 registration statement, detailing its initial public offering of 24.39 million shares, a strategic focus on digital learning solutions, and plans to use IPO proceeds to significantly reduce its substantial debt.

Papa Medical Inc., a pioneering provider of end-to-end Hemp dosing solutions, has filed an amended S-1 registration statement for its initial public offering of 1,250,000 shares at an estimated price of US$4 per share, aiming to raise US$5 million before expenses for R&D, plant upgrades, and sales expansion.

Citius Oncology, Inc. has filed an S-1 registration statement to raise up to $15 million through a public offering of common stock and warrants, aiming to fund the commercialization of its recently FDA-approved oncology drug LYMPHIR, while facing substantial doubt about its ability to continue as a going concern.

A healthcare software company is seeking to register millions of shares for public and secondary offerings while grappling with significant financial losses, a going concern warning, and multiple Nasdaq listing deficiencies.

A Nevada-based mineral exploration company is registering shares for resale by existing stockholders while navigating significant financial losses and regulatory challenges for its primary gold project in California.

Picard Medical, Inc., developer of the only FDA-approved total artificial heart, is seeking to raise $15.4 million in its initial public offering on the NYSE American, despite a history of substantial net losses and an auditor's warning about its ability to continue as a going concern.

Trailblazer Acquisition Corp., a newly formed blank check company, files an S-1 registration statement for a $200 million initial public offering to seek a business combination in media, tech, sports, or retail.

WhiteFiber, a leading AI infrastructure provider, is launching its initial public offering as a spin-off from Bit Digital, focusing on high-performance computing data centers and cloud services.

Firefly Aerospace, a leader in space and defense technology, is launching its initial public offering following a successful commercial Moon landing and significant contract backlog.

Artelo Biosciences, a clinical-stage biopharmaceutical company, filed an S-1 registration statement for the resale of up to 920,092 shares of common stock and warrants by selling securityholders, while simultaneously disclosing substantial doubt about its ability to continue as a going concern and non-compliance with Nasdaq's minimum stockholders' equity requirement.

BioVie Inc., a clinical-stage biopharmaceutical company, has filed an amended S-1 registration statement for a public offering of units to raise approximately $13.5 million, as it navigates significant clinical trial protocol violations for its Alzheimer's drug candidate and addresses a 'going concern' doubt from its auditors.

Crown Reserve Acquisition Corp. I, a blank check company, filed an amended S-1 registration statement for its initial public offering of 15,000,000 units at $10.00 per unit, aiming to raise $150 million for a business combination primarily in the pharma, medical technology, medical equipment, and healthcare IT industries.

HCM III Acquisition Corp., a blank check company led by SPAC veterans Shawn Matthews and Steven Bischoff, is launching a $220 million initial public offering to pursue business combinations primarily in the technology and software infrastructure sectors serving financial services, real estate, and asset management industries.

Soluna Holdings, Inc. filed an Amendment No. 2 to its Form S-1 Registration Statement to include legal opinions and consents related to its proposed offering of common stock and various warrants.

Cloudastructure, Inc. has filed an S-1 registration statement for the resale of up to 5,000,000 shares of Class A common stock by Atlas Sciences, LLC, while also outlining its right to sell up to $50 million in Class A common stock to Atlas under a previously established equity purchase agreement.

Thoughtful Media Group Incorporated, a Southeast Asia-focused digital advertising and multi-channel network company, has filed an S-1/A registration statement for its initial public offering on the Nasdaq Capital Market, seeking to raise approximately $15.1 million despite recent net losses and a 'going concern' warning from its auditors.

Eva Live Inc., a digital marketing and media monetization company, has filed an S-1 registration statement for a public offering of 2.5 million units, seeking to list its common stock and warrants on the NASDAQ Capital Market, despite ongoing concerns about its ability to continue as a going concern.

Crown Reserve Acquisition Corp. I, a newly formed blank check company, has filed an amended registration statement for its initial public offering of $150 million, aiming to acquire a business in the pharma, medical technology, medical equipment, or healthcare IT industries within 24 months.

Fold Holdings, Inc., a bitcoin financial services company, has entered into a $250 million equity purchase facility with SZOP Opportunities I, LLC to bolster its treasury and operations, while continuing to expand its bitcoin-centric product offerings despite significant net losses driven by fair value adjustments.

Solarius Capital Acquisition Corp., a newly formed blank check company, filed an amended S-1 registration statement for its initial public offering of 15 million units at $10.00 per unit, aiming to raise $150 million to pursue a business combination in the asset management, wealth management, and financial services sectors.

BriaCell Therapeutics Corp. has filed an S-1/A registration statement for a public offering of up to 6,825,938 common and pre-funded units, while reporting strong clinical data for its Bria-IMT and Bria-OTS immunotherapies in metastatic breast cancer.

Lake Superior Acquisition Corp., a British Virgin Islands blank check company, filed an amended S-1 registration statement for a $100 million initial public offering, aiming to pursue a business combination in high-potential sectors like energy storage, social media, and consumer staples, despite facing immediate and substantial dilution for public shareholders and a going concern warning from its auditor.

Lixte Biotechnology Holdings, Inc. has completed two significant capital raises totaling $6.55 million to address its financial needs and Nasdaq listing compliance, while facing ongoing clinical trial hurdles and a 'going concern' warning from auditors.

Liberty Star Uranium & Metals Corp., an exploration-stage company, has entered into a $10 million equity financing agreement with GHS Investments LLC to fund its operations, while its auditors express substantial doubt about its ability to continue as a going concern.

Quantumsphere Acquisition Corporation, a newly formed blank check company, has filed an amended registration statement for its initial public offering of 6 million units at $10.00 each, aiming to raise $60 million for a business combination while disclosing significant risks related to its SPAC structure and management's ties to China.

1847 Holdings LLC has filed an amended registration statement to register 778.5 million common shares for resale by selling shareholders, following its delisting from NYSE American and facing substantial potential dilution from warrants.

Safe & Green Holdings Corp. filed an amended S-1 registration statement for the resale of over 20 million shares by a selling stockholder, while navigating ongoing Nasdaq listing challenges and pursuing strategic acquisitions and capital raises.

Windtree Therapeutics, a biotechnology company, has filed an S-1/A registration statement to allow selling stockholders to resell up to 62.6 million shares of common stock, with the company not receiving any proceeds from these sales, while facing substantial doubt about its ability to continue as a going concern.